Showing results (181-190 of 462) with videos related to
Sort By:
Pageof 47
The European Journal of Neuroscience|March 11, 2004
Blockade of the NPY Y5 receptor potentiates circadian responses to light: complementary in vivo and in vitro studiesP C Yannielli, J McKinley Brewer, M E HarringtonCurrent Pharmaceutical Design|May 14, 2008
Structure-based rationale for interleukin 5 receptor antagonismTetsuya Ishino, Adrian E Harrington, Hosahudya Gopi, et al.The European Journal of Neuroscience|November 17, 1999
Role of membrane conductances and protein synthesis in subjective day phase advances of the hamster circadian clock by neuropeptide YA C Hall, G Earle-Cruikshanks, M E HarringtonArchives of Neurology|September 1, 1979
Uptake and release of putative neurotransmitters. Measurements in regions of the normal and Newcastle disease virus-infected mouse brainS C Bondy, J S Burks, M E HarringtonNeuroscience|June 21, 2002
Is novel wheel inhibition of per1 and per2 expression linked to phase shift occurrence?P C Yannielli, J McKinley Brewer, M E HarringtonCurrent Opinion in Immunology|April 18, 2006
Expanding the effector CD4 T-cell repertoire: the Th17 lineageLaurie E Harrington, Paul R Mangan, Casey T WeaverOrganic Letters|February 28, 2004
Dimerization of 9-phenylethynylfluorene to di-indeno-naphthacene and dispiro-[fluorene-dihydronaphthacene-fluorene]: an X-ray crystallographic and NMR studyLaura E Harrington, James F Britten, Michael J McGlincheyJournal of Thrombosis and Haemostasis : JTH|March 6, 2004
Rapid generation of thrombin by atheroma and plateletsJ Niemetz, J T Fallon, E Harrington, et al.Talanta|November 1, 1977
Determination of acid-soluble and total rhodium on alumina-supported catalystsW R Bramstedt, D E Harrington, K M AndrewsJournal of Immunology (Baltimore, Md. : 1950)|October 11, 2011
Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitisWen-I Yeh, Ian L McWilliams, Laurie E HarringtonPageof 47